CHARM Therapeutics Company
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Industry:
AI, Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2021-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
50000000
Last Funding Date:
2022-06-09
Last Funding Type:
Series A
Register and Claim Ownership